Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T16:38:50.886Z.
Calculation as of: 2026-10-06T16:38:50.886Z.
Quote observation: 2026-10-06T16:34:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 651b3973db42e019715e3a8a4e975a06fcddd3d3dc4e12dda44c0d1ac22a80ea
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$22.31M
EV/FCF Ratio
4.34x
TTM Avg
11.24x
3Y Avg
10.04x
5Y Avg
10.04x
Market Cap
$18.86M
EV/FCF Ratio
N/A
TTM Avg
281.92x
3Y Avg
1403.45x
5Y Avg
1403.45x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum BioPharma Ltd. (QNTM) | $20.80M | N/A | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.72M | N/A | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $21.68M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $18.74M | N/A | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $18.95M | N/A | 232.26x | 232.26x | 232.26x |
| LeonaBio, Inc. (LONA)vs › | $22.24M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.31M | 4.34x | 11.24x | 10.04x | 10.04x |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.86M | N/A | 281.92x | 1403.45x | 1403.45x |
| Rein Therapeutics Inc. (RNTX)vs › | $22.97M | N/A | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.60M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
